Reneo Pharmaceuticals repurchases 576,443 shares from vTv Therapeutics for $4.4M

OnKure Therapeutics, Inc.

Repurchased 576,443 shares at $7.64/share ($4.4M aggregate) from vTv Therapeutics LLC in a private transaction.
Common Stock Repurchase Agreement dated October 30, 2023, with no further repurchase commitments disclosed.
Repurchased shares will be retired or held as treasury stock, per standard practice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.